Wei-Chi Wu

603 total citations
11 papers, 465 citations indexed

About

Wei-Chi Wu is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Wei-Chi Wu has authored 11 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 8 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Wei-Chi Wu's work include Retinal Diseases and Treatments (8 papers), Retinopathy of Prematurity Studies (7 papers) and Retinal Development and Disorders (4 papers). Wei-Chi Wu is often cited by papers focused on Retinal Diseases and Treatments (8 papers), Retinopathy of Prematurity Studies (7 papers) and Retinal Development and Disorders (4 papers). Wei-Chi Wu collaborates with scholars based in Taiwan, United States and Malaysia. Wei-Chi Wu's co-authors include Chi‐Chun Lai, An‐Ning Chao, Nan‐Kai Wang, Kuan‐Jen Chen, Tun‐Lu Chen, Yen‐Po Chen, Yih‐Shiou Hwang, Reyin Lien, Chia-Pang Shih and Shawn Tsai and has published in prestigious journals such as Ophthalmology, Retina and JAMA Ophthalmology.

In The Last Decade

Wei-Chi Wu

11 papers receiving 444 citations

Peers

Wei-Chi Wu

RNMI

OPHTH

PRM

PPCH

MB

Anjli Hussain India

Lorenzo Orazi Italy

Brian R. Connolly United States

Arnold Loewenstein Israel

Divya Balakrishnan India

B Lanigan Ireland

Monika Andrassi-Darida Germany

Chiharu Shima Japan

Marco H. Ji United States

Isabel Prieto Portugal

Anjli Hussain India

Wei-Chi Wu

291 ×0.7

RNMI

271 ×1.2

OPHTH

119 ×0.5

PRM

97 ×0.6

PPCH

63 ×0.9

MB

Citations per year, relative to Wei-Chi Wu Wei-Chi Wu (= 1×) peers Anjli Hussain

Countries citing papers authored by Wei-Chi Wu

Since Specialization

Citations

This map shows the geographic impact of Wei-Chi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chi Wu more than expected).

Fields of papers citing papers by Wei-Chi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Chi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chi Wu. The network helps show where Wei-Chi Wu may publish in the future.

Co-authorship network of co-authors of Wei-Chi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Chi Wu. A scholar is included among the top collaborators of Wei-Chi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Chi Wu. Wei-Chi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Wu, Shuang, et al.. (2025). TEMPORAL RETINAL VESSEL ANGLE AS A BIOMARKER FOR FAMILIAL EXUDATIVE VITREORETINOPATHY. Retina. 45(9). 1769–1779. 1 indexed citations

2.

Wu, Wei-Chi, et al.. (2018). Short-term postoperative perfluoro-n-octane tamponade for pediatric recurrent retinal detachment. Taiwan Journal of Ophthalmology. 8(4). 249–249. 1 indexed citations

3.

Wang, Jung‐Pan, Laura Liu, Eugene Yu‐Chuan Kang, et al.. (2017). MULTIMODAL IMAGING OF MOSAIC RETINOPATHY IN CARRIERS OF HEREDITARY X-LINKED RECESSIVE DISEASES. Retina. 38(5). 1047–1057. 13 indexed citations

4.

Wu, Wei-Chi, Chia-Pang Shih, Reyin Lien, et al.. (2016). SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY. Retina. 37(4). 694–701. 102 indexed citations

5.

Chuluunbat, Tsengelmaa, Nan‐Kai Wang, Reyin Lien, et al.. (2016). Nonresponse and Recurrence of Retinopathy of Prematurity After Intravitreal Ranibizumab Treatment. Ophthalmic surgery, lasers & imaging retina. 47(12). 1095–1105. 9 indexed citations

6.

Wang, Nan‐Kai, Laura Liu, Shawn Tsai, et al.. (2015). Clinical presentations of X-linked retinoschisis in Taiwanese patients confirmed with genetic sequencing.. PubMed. 21. 487–501. 20 indexed citations

7.

Wu, Wei-Chi, Reyin Lien, Pei‐Ju Liao, et al.. (2015). Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity. JAMA Ophthalmology. 133(4). 391–391. 134 indexed citations

8.

Chen, Yi‐Hsing, Reyin Lien, Shawn Tsai, et al.. (2014). NATURAL HISTORY OF RETINOPATHY OF PREMATURITY. Retina. 35(1). 141–148. 19 indexed citations

9.

Wu, Wei-Chi, Yi‐Hsing Chen, Chi‐Chun Lai, et al.. (2013). Retinopathy of Prematurity in Neonatal Patients with Birth Weight Greater than 1500 g in Taiwan. Biomedical Journal. 36(2). 84–84. 11 indexed citations

10.

Wu, Wei-Chi, Chia-Pang Shih, Nan‐Kai Wang, et al.. (2012). Visual Acuity, Optical Components, and Macular Abnormalities in Patients with a History of Retinopathy of Prematurity. Ophthalmology. 119(9). 1907–1916. 127 indexed citations

11.

Wang, Nan‐Kai, Lan‐Hsin Chuang, Chi‐Chun Lai, et al.. (2012). Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature. Documenta Ophthalmologica. 125(1). 51–62. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact